J. Roncalés

Tratamiento anticoagulante oral: una historia interminable

J. Roncalés, 2005 .

Fixed‐dose low‐molecular‐weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: a prospective cohort study

M. Monreal, L. Zacharski, J. Roncalés, 2004, Journal of thrombosis and haemostasis : JTH.

Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalaemia

M. Monreal, E. Lafoz, J. Roncalés, 2004, European Journal of Clinical Pharmacology.

Effects of inhaled platelet activating factor on bronchial responsiveness in patients with symptomatic and asymptomatic pulmonary embolism.

M. Monreal, J. Ruiz, E. Monso, 1992, Chest.

Should Patients with Deep Vein Thrombosis Alone be Treated as Those with Concomitant Asymptomatic Pulmonary Embolism? A Prospective Study

H. Büller, M. Monreal, A. Lensing, 2002, Thrombosis and Haemostasis.

Paraprotein-induced defective haemostasis in a dog with IgA (kappa-light chain) forming myeloma.

Y. Espada, R. Ruiz de Gopegui, F. Millá, 1994, Veterinary clinical pathology.

Analysis of compliance with oral contraception in Spain.

J. L. Dueñas, J. Balasch, J. J. Parrilla, 1996, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Preoperative platelet count and postoperative blood loss in patients undergoing hip surgery: an inverse correlation.

M. Monreal, E. Lafoz, J. Roca, 1996, Haemostasis.

Effects of recombinant hirudin on D dimer levels before and after experimental venous thrombosis.

M. Monreal, L. Monreal, J. Monasterio, 1994, Haemostasis.

Platelet count and the risk of bleeding in hospitalized patients with venous thromboembolism starting anticoagulant therapy.

M. Monreal, A. Cuxart, J. Roncalés, 1997, Haemostasis.